MAGE1
|
EADPTGHSY
|
HLA-A*0101
|
Melanoma
|
Detection
|
Fab
|
Fab-G8
|
Phage
|
[20]
|
EADPTGHSY
|
HLA-A*0101
|
Melanoma
|
CAR-T
|
Fab
|
Fab-G8
|
Phage
|
[21]
|
EADPTGHSY
|
HLA-A*0101
|
Melanoma
|
CAR-T
|
Fab
|
Fab-G8/Fab-Hyb3
|
Phage
|
[22]
|
GP100
|
KTWGQYWQV
|
HLA-A*0201
|
Melanoma
|
Detection
|
Fab
|
G2D12, G3G4
|
Phage
|
[23, 24]
|
IMDQVPFSV
|
HLA-A*0201
|
Melanoma
|
Detection
|
Fab
|
1A9, 1C8, 1A11, 1A7
|
Phage
|
[23, 24]
|
YLEPGPVTV/A
|
HLA-A*0201
|
Melanoma
|
detection/inhibition
|
Fab
|
2F1, 2B2, 2C5, 2D1
|
Phage
|
[23, 24]
|
IMDQVPFSV
|
HLA-A*0201
|
Melanoma
|
Immunotoxin
|
scFv-PE38
|
G1
|
Phage
|
[16]
|
ITDQVPFSV
|
HLA-A*0201
|
Melanoma
|
CAR-T
|
sdAb-CAR
|
GPA7
|
Phage
|
[25]
|
LLLTVLTVL
|
HLA-A*0201
|
Melanoma
|
Immunotoxin
|
Fab
|
2F1-PE38KDEL
|
Phage
|
[26]
|
hTERT
|
ILAKFLHWL
|
HLA-A*0201
|
Melanoma, prostate cancer
|
Detection/inhibition
|
Fab
|
4A9, 4G9
|
Phage
|
[27]
|
RLVDDFLLV
|
HLA-A*0201
|
Melanoma, prostate cancer
|
Detection/inhibition
|
Fab
|
3H2, 3G3
|
Phage
|
[27]
|
MUC1
|
LLLTVLTVV
|
HLA-A*0201
|
Breast cancer
|
Detection
|
Fab
|
M2B1, M2F5, M3A1, M3B8, M3C8
|
Phage
|
[28]
|
NY-ESO-1
|
SLIMWITQC
|
HLA-A*0201
|
Melanoma
|
Detection/inhibition
|
Fab
|
3M4E5;3M4F4;T1
|
Phage
|
[29]
|
MAGE3
|
FLWGPRALV
|
HLA-A*0201
|
Melanoma
|
Detection
|
mIgG1
|
7D4, 8A11, 2G12, 9E6
|
Hybridoma
|
[30]
|
hCGβ
|
GVLPALPQV
|
HLA-A*0201
|
Ovarian, colon, breast cancer
|
CDC, ADCC, direct
|
mIgG2a
|
RL4B/3.2G1
|
Hybridoma
|
[31]
|
GVLPALPQV
|
HLA-A*0201
|
Ovarian, colon, breast cancer
|
Detection
|
IgG1
|
1B10
|
Hybridoma
|
[21]
|
TMTRVLQGV
|
HLA-A*0201
|
Ovarian, colon, breast cancer
|
Detection
|
IgG1
|
3F9
|
Hybridoma
|
[32]
|
Her2/Neu
|
KIFGSLAFL
|
HLA-A*0201
|
Breast, colon cancer
|
Detection/inhibition
|
IgG1
|
1B8
|
Hybridoma
|
[33]
|
Melan-A/MART-1
|
EAAGIGILTV
|
HLA-A*0201
|
Melanoma
|
Detection
|
Fab
|
2M3F11;3N4E9;2N4B4;E6;H4
|
Phage
|
[34]
|
EAAGIGILTV
|
HLA-A*0201
|
Melanoma
|
Immunotoxin
|
Fab-PE38
|
CAG10, CLA12
|
Phage
|
[26]
|
TARP
|
FLRNFSLML
|
HLA-A*0201
|
Breast, prostate cancer
|
Immunotoxin
|
Fab-PE38
|
Fab-D2
|
Phage
|
[35]
|
p53
|
RMPEAAPPV
|
HLA-A*0201
|
Various tumors, breast cancer
|
ADCC, ADCP, CDC
|
IgG1
|
T1-116C
|
Hybridoma
|
[36]
|
RMPEAAPPV
|
HLA-A*0201
|
–
|
Detection
|
IgG1, IgG2b
|
T1-29D, T1-84C
|
Hybridoma
|
[37]
|
GLAPPQHLIRV
|
HLA-A*0201
|
–
|
Detection
|
IgG1, IgG2a, IgG1
|
T2-108A, T2-2A, T2-116A
|
Hybridoma
|
[37]
|
Tyrosinase
|
YMDGTMSQV
|
HLA-A*0201
|
Melanoma
|
Detection
|
Fab
|
TA2
|
Phage
|
[38]
|
p68
|
YLLPAIVHI
|
HLA-A*0201
|
Breast cancer
|
ADCP/direct
|
mIgG2a
|
RL6A
|
Hybridoma
|
[39]
|
MIF
|
FLSELTQQL
|
HLA-A*0201
|
Breast cancer
|
CDC, ADCC, direct
|
IgG2a
|
RL21A
|
Hybridoma
|
[40]
|
Proteinase 3
|
VLQELNVTV
|
HLA-A*0201
|
AML
|
CDC, CAR-T
|
IgG2a
|
8F4
|
Hybridoma
|
[41, 42]
|
WT1
|
RMFPNAPYL
|
HLA-A*0201
|
Leukemia, ovarian, colon cancer
|
ADCC, ADCP
|
hIgG1
|
ESK1
|
Phage
|
[15]
|
RMFPNAPYL
|
HLA-A*0201
|
Leukemia
|
CAR-T
|
Fab
|
F2, F3
|
Phage
|
[43]
|
RMFPNAPYL
|
HLA-A*0201
|
Leukemia
|
ADCC, CAR-T
|
scFv
|
Clone45
|
Phage
|
[44]
|
HA-1H
|
VLHDDLLEA
|
HLA-A*0201
|
Leukemia
|
CAR-T
|
scFv, scFv-CAR
|
#131
|
Phage
|
[11]
|
PRAME
|
ALYVDSLFFL
|
HLA-A*0201
|
Leukemia, lymphoma
|
ADCC, CDC, ADCP
|
hIgG1
|
Pr20
|
Phage
|
[45]
|
HTLV-1(TAX-11)
|
LLFGYPVYV
|
HLA-A*0201
|
T-Cell leukemia/lymphoma
|
Detection
|
Fab
|
T3A4,T3D4;T3F2;T3E3;T3D3;T2H9
|
Phage
|
[46, 47]
|
Influenza(M1-58)
|
GILGFVFTL
|
HLA-A*0201
|
Flu
|
Detection
|
Fab
|
M1-D1,M1-G8;M1-D12;M1-A2
|
Phage
|
[48]
|
HBV (ENV-183)
|
FLLTRILTI
|
HLA-A*0201
|
Hepatitis B
|
Detection/intracellular delivery of cargo
|
mIgG1
|
N/A
|
Hybridoma
|
[49]
|
HIV-1 (Nef-105)
|
RRQDILWIY
|
HLA-C*07
|
AIDS
|
Surface co-expression with fas-ligand on virion particle
|
Fab
|
C3
|
Phage
|
[50]
|
HIV-1 (elf4G-720)
|
VLMTEDIKL
|
HLA-A*0201
|
AIDS
|
Detection
|
mIgG1
|
4F7
|
Hybridoma
|
[51]
|
HIV-1 (Nef-138)
|
RYPLTFGWCF
|
HLA-A*2401
|
AIDS
|
Detection
|
Fab
|
scFv#3, scFv#27
|
Phage
|
[52]
|
CMV (pp65-495)
|
NLVPMVATV
|
HLA-A*0201
|
Mucoepidermoid carcinoma
|
Detection
|
Fab
|
H9
|
Phage
|
[53]
|